Israeli company that claims cancer cure faces years of testing for US market — even if it works

An Israeli biotech told the Jerusalem Post it will develop a cancer cure "within a year's time" — but the company has only tested the treatment in mice so far.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.